2Hilger I,Rapp A,Creulich KO,et al.Assessment of DNA damage in target tumor cells after thermoablation in mice.Radiology,2005,237 (2):500-506.
3Ahleis O,Hildebrandt B,Dicing A,et al.Stress induced changes in lymphocyte subpopulations and associated cytokines during whole body hyperthermia of 41.8 -42.2degcess C.Eur J Appl physiol,2005,95 (4):298-306.
4Atanackovic D,Pollok K,Faltz C,et al.Patients with solid tumors treated with high-temperature whol body hyperthermia show a redistribution of raive/memory T-Cell subtypes.Am J physiol Regul Integr Comp physiol,2006,290(3):585 -594.
5Milani V,Noessner E.Affects of thermal stress on tumor antigenicity and recognition by immune effectorcells.Cancer Immunol Immunother,2006,55(3):312-319.
6Koga T,Harada H,Shi TS,et al.Hyperthormia suppnesses the cytotoxicity of NK cells via down-regulation of perforin/granzyme B expression.Bio chem Biophyg Res Common,2005,337(4):1319 -1323.
7Calderwood SK,Theriault JR,Cong J.How is the immune response affected by hyperthermia and heat shock proteins? Int J Hyperthermia,2005,21(8):713-716.
8Song CW,Park HI,Lee CK.et al.Implications of increased tumor blood flow and oxygenation caused by mild temperature hyperthermia in tumor treatment.Int J Hyperthermia,2005,21 (8):761 -767.
9Zhang S,Xu G,liu C,et al.Clinial study of recombinant adenovirus P53 (Adp 53) combined wiyh hyperthermia in advanced cancer(a repot of 15 cases).Int J Hyperthermia,2005,21(7):631-636.
10Vertrees RA,Das GC,Coscio,AM,et al.A mechanism of hyperthermia induced apoptosis in rag-transformed lung cells.Mol Carcinog,2005,44(2):111-121.
5Moore DF,Lee JS.Staging and prognostic factors:non-small cell lung cancer.In:Pass HI,Mitchell JB,Johnson DH,eds.Lung cancer:principles and practice.Philadelphia:Lippincott,1996.481-494.
6Furuse K,Fukuoka M,Kawahara M,et al.Phase Ⅲ study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin,cindesine and cisplatin in unresectable stage Ⅲ non-small-cell lung cancer.J Clin Oncol,1999,17:2692-2699.
8Kupelian PA,Komaki R,Allen P.Prognostic factors in the treatment of node-negative non-small cell lung carcinoma with radiotherapy alone.Int J Radiat Oncol Biol Phys,1996,36:607-611.
9Fletcher GH.Clinical dose-response curves of human malignant epithelial tumors.Br J Radiol,1973,46:1-12.
10Ha CS,Kijewski PK,Langer MP.Gain in target dose from using computer controlled radiation therapy (CCRT) in the treatment of non-small cell lung cancer.lnt J Radiat Oncol Biol Phys,1993,26:335-339.
1Puglisi M, Dolly S, Faria A, et al. Treatment options for small cell lung cancer - do we have more choice [ J]. Br J Cancer, 2010,102 (4) :629-638.
2Lipp HP, Hartmann JT. Platinum compounds: metabolism, toxicity and supportive strategies [J]. Praxis, 2005,94(6) :187-198.
3Ohguri T, Imada H, Yahara K, et al. Radiotherapy with 8-MHz radiofrequency-capacitive regional hyperthermia for stage III non- small-cen lung cancer: the radiofrequeney-output power correlates with the intraesophageal temperature and clinical outcomes [ J]. Im J Radiat Oncol Biol Phys, 2009,73( 1 ) :128-135.
4Ohguri T, Imada H, Narisada H, et al. Systemic chemotherapy using paclitaxel and carboplatin plus regional hyperthermia and hyperbaric oxygen treatment for non-small cell lung cancer with multiple pulmonary metastases: preliminary results[J]. Int J Hyperthermia, 2009,25 (2) : 160-167.
